Classical Swine Fever (CSF) has caused several outbreaks in EU Member States with grave 19 economic consequences. Several times the diagnosis of CSF was made too late partially due 20 to non-specific clinical signs which did not raise suspicion for CSF. Virulence of CSF virus 21 isolates (CSFV) still remains a subject of discussion and speculation as sufficient knowledge 22 33 Keywords 34
is still not available. Six uncharacterised CSFV isolates from 1996 until 2007 were assessed 23 in animal experiments for their clinical virulence in order to broaden the knowledge about 24 circulating CSFV and thereby assist disease eradication. A clinical (CS) and pathological 25 score were applied and further extended by additional parameters to a modified CS (mCS) 26 including case fatality, antibody production and leukocyte count. 27
The unknown CSFV isolates could be classified as moderately or highly virulent. The 28 inclusion of additional parameters, especially case fatality, into the mCS gave a more reliable 29 classification of virulence, proving that there are clinical signs and laboratory parameters of 30 blood which can be recognised. Therefore a subclinical course of infection is unlikely, 31 especially in weaner pigs. 32
Introduction 38
Classical Swine Fever (CSF), which is among the diseases notifiable to the World 39
Organisation for Animal Health (OIE) (Anonymous, 2004), occasionally causes sporadic 40 epidemics in EU Member States and is endemic in a number of Third Countries worldwide. 41
Since CSF has been generally eradicated from the EU, the control measures for CSF are based 42 on a non-vaccination policy (Anonymous, 2001) . However, during the last decades several 43 (Kubin 1967; 57 Mittelholzer et al., 2000) or differences in the genome (Moormann et al., 1996; Mayer et al., 58 2003) . Most of these characterisations are restricted to individual strains and they do not 59 apply for other CSFV strains. Whether characterisation of virulence performed about three 60 decades ago, still applies to CSFV isolated since the vaccination policy in the EU stopped at 61 the beginning of the nineties is therefore questionable. Regarding the incubation period, all six so far unknown CSFV had a shorter incubation period 142
(3-5 days) compared to CSF0634 and CSF0277 (6-8) days. The mean CS ranged between 10 143 and 17.6 points. The lowest CS was 10 for CSF0650 and the highest score 17.6 for CSF0634 144 (see Table 1 ). Regarding case fatality, in each group at least one pig died (see Table 1 ). Pigs Page 7 of 14 A c c e p t e d M a n u s c r i p t 7 infected with CSF0634 and CSF0870, respectively, showed the highest case fatality of 100 %, 146 whereas pigs infected with CSF0650 showed the lowest case fatality rate of 20 %. None of 147 the pigs infected with CSF0634 and CSF0849 had a detectable homologue CSF antibody titre 148 at 14 dpi. From pigs infected with CSF0277, CSF0854, CSF0864, and CSF0870, respectively, 149 only one pig in each group started to produce CSF antibodies at 14 dpi against the homologue 150 virus (neutralizing dose 50 % (ND 50 ) 15-30). CSF0650 and CSF0695 both induced CSF 151 antibody titres between 10 and 80 ND 50 . The leukocyte count decreased in all investigated 152 CSFV infected pigs below 10 G/l (see Table 1 ). The leukocyte count for pigs infected with 153 CSF0849, CSF0854, CSF0864, and CSF870 were not performed for technical reasons. 154 CSF0634 and CSF0854 scored the highest pathological score (15.4 and 15.25 respectively), 155 followed by CSF0849 (14.25). CSF0650 and CSF0277 scored rather similar (5.6 and 5 156 respectively) the lowest pathological scores. Pathological findings were most obvious in 157 lymphnodes upon infection with all eight CSFV isolates (see Table 2 ). Scores for skin lesions, 158
representing the classical haemorrhagic picture, ranged from 0.2 in CSF0650 up to 2.5 in 159
CSF0849. 160
The mCS (see Table 1 ) clearly defines CSF0634, CSF0849 and CSF0854 as highly virulent, 161 whereas CSF0864 and CSF870 are borderline between highly and moderately virulent. Regarding the introduction of the additional parameter case fatality, it did not always correlate 190 with a high CS. Animals with the highest CS also had a high case fatality rate (CSF0634), 191 however, CSF0870 with a case fatality rate of 100% had a clinical score of only 12.5. 192 Furthermore CSF0277 had a lower CS than CSF0695 but a higher case fatality . 193
Consequently, high case fatality is not necessarily associated with a high CS. Therefore case 194 fatality is an important parameter which needs to be included, when evaluating virulence. 195 CSF0277 had also been characterised in the marker vaccine trial performed by EU member 196 states (Uttenthal et al., 2001) . There, the case fatality differed in pigs from different countries.
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Regarding antibody production against CSF, CSF695 and CSF650 both induced significant 201 CSF antibody titres at 14 dpi (see Table 1 ). This lowers the mCS and may lead to recovery of 202 infected animals with less obvious clinical signs. On the other hand, these CSF antibody titres 203 would be easy to detect in laboratory diagnosis using commercial ELISAs or neutralisation 204 and can now be characterised as highly virulent in the age class of weaner pigs. Previously 208 CSF0634 had been characterised as moderately virulent (Floegel-Niesmann et al., 2003) . 209
The CSFV classified as highly virulent in the mCS had the highest total pathological score 210 (CSF0634, CSF0849, and CSF0854). This indicates that there is a correlation between the 211 pathological signs and the classification of virulence in the mCS: high virulence is associated 212 with increased pathological lesions. However, many pathological signs were non-specific 213 with lymphadenosis dominating the picture. 
